SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001104659-12-074445
Filing Date
2012-11-06
Accepted
2012-11-06 08:00:50
Documents
10
Period of Report
2012-09-30
Filing Date Changed
2012-11-06

Document Format Files

Seq Description Document Type Size
1 10-Q a12-19931_110q.htm 10-Q 981726
2 EX-31.1 a12-19931_1ex31d1.htm EX-31.1 13513
3 EX-31.2 a12-19931_1ex31d2.htm EX-31.2 12787
4 EX-32.1 a12-19931_1ex32d1.htm EX-32.1 6990
  Complete submission text file 0001104659-12-074445.txt   5243132

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rigl-20120930.xml EX-101.INS 754311
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20120930.xsd EX-101.SCH 38289
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20120930_cal.xml EX-101.CAL 34803
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rigl-20120930_lab.xml EX-101.LAB 558184
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20120930_pre.xml EX-101.PRE 248469
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20120930_def.xml EX-101.DEF 176726
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 121181740
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1